Utah Medical Products Inc UTMD
Utah Medical Products Inc (Nasdaq: UTMD) is an endocrine/women's health medical device company. Its next catalyst on record is Litigation cases in two courts will apparently go to trial in 2027. (2027).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: Litigation cases in two courts will apparently go to trial in 2027. (2027). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Filshie Clip System | Female sterilization (PMA-approved 1996) | unclear | NA_NON_THERAPEUTIC |
| Deltran disposable pressure transducer | Blood pressure monitoring | unclear | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other endocrine/women's health companies
- DexCom, Inc. DXCM
- Sera Prognostics, Inc. SERA
- Femasys Inc FEMY
- Pulsenmore Ltd. PLSM
- Trinity Biotech PLC TRIB
- INVO Fertility, Inc. IVF
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.